Showing results (71-80 of 103) with videos related to

Sort By:
Pageof 11
Journal of Cardiology|March 31, 2010
Mid-term mortality of very elderly patients with acute myocardial infarction with or without coronary interventionKatsuro Kashima, Daisuke Ikeda, Hideki Tanaka, et al.
International Journal of Hematology|April 15, 2022
Antibody response to COVID-19 vaccine in 130 recipients of hematopoietic stem cell transplantationTakafumi Tsushima, Toshiki Terao, Kentaro Narita, et al.
Transplantation and Cellular Therapy|July 9, 2023
Concordance between HokUS-10 Scoring and Transjugular Liver Biopsy for the Diagnosis of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Allogeneic Stem Cell TransplantationAmi Fukumoto, Koichi Honma, Shuichiro Nakaminato, et al.
Frontiers in Medicine|April 11, 2022
Impaired Antibody Response Following the Second Dose of the BNT162b2 Vaccine in Patients With Myeloproliferative Neoplasms Receiving RuxolitinibDaisuke Ikeda, Toshiki Terao, Daisuke Miura, et al.
Scientific Reports|December 15, 2021
Association of loss of spleen visualization on whole-body diffusion-weighted imaging with prognosis and tumor burden in patients with multiple myelomaToshiki Terao, Youichi Machida, Ukihide Tateishi, et al.
British Journal of Haematology|February 16, 2022
Depletion of CD38-positive regulatory T cells by anti-CD38 monoclonal antibodies induces a durable response to SARS-CoV-2 vaccination in patients with plasma cell dyscrasiaToshiki Terao, Takashi Naduka, Daisuke Ikeda, et al.
Frontiers in Oncology|March 30, 2026
Case Report: Secondary neurolymphomatosis successfully treated with sequential Bruton's tyrosine kinase inhibitor and bispecific antibody therapyMitsuaki Oura, Masanori Toho, Daisuke Ikeda, et al.
British Journal of Haematology|November 8, 2022
Antibody status following booster vaccination against SARS-CoV-2 virus in patients with haematologic malignanciesDaisuke Ikeda, Toshiki Terao, Ami Fukumoto, et al.
Haematologica|December 19, 2025
Impact of the plasma cell quantification method on the International Myeloma Working Group diagnostic criteria for MGUS/SMMAtsushi Uehara, Hajime Sakuma, Fuminari Fujii, et al.
Leukemia & Lymphoma|October 8, 2025
Soluble BCMA as a biomarker reflecting tumor volume and treatment response in Waldenström macroglobulinemiaMitsuaki Oura, Daisuke Ikeda, Shuichi Aikawa, et al.
Pageof 11